Article Versions Notes

Hitchon CA, Bowdish DME, Boire G, Fortin PR, Flamand L, Chandran V, Dayam RM, Gingras A-C, Card CM, Colmegna I, et al. Methotrexate and Tumor Necrosis Factor Inhibitors Independently Decrease Neutralizing Antibodies after SARS-CoV-2 Vaccination: Updated Results from the SUCCEED Study. Vaccines. 2024; 12(9):1061. https://doi.org/10.3390/vaccines12091061

Hitchon, Carol A, Dawn M. E. Bowdish, Gilles Boire, Paul R. Fortin, Louis Flamand, Vinod Chandran, Roya M. Dayam, Anne-Claude Gingras, Catherine M. Card, Inés Colmegna, and et al. 2024. "Methotrexate and Tumor Necrosis Factor Inhibitors Independently Decrease Neutralizing Antibodies after SARS-CoV-2 Vaccination: Updated Results from the SUCCEED Study" Vaccines 12, no. 9: 1061. https://doi.org/10.3390/vaccines12091061

Hitchon, C. A., Bowdish, D. M. E., Boire, G., Fortin, P. R., Flamand, L., Chandran, V., Dayam, R. M., Gingras, A.-C., Card, C. M., Colmegna, I., Larché, M. J., Kaplan, G. G., Lukusa, L., Lee, J. L. F., Bernatsky, S., & on behalf of the SUCCEED Investigative Team. (2024). Methotrexate and Tumor Necrosis Factor Inhibitors Independently Decrease Neutralizing Antibodies after SARS-CoV-2 Vaccination: Updated Results from the SUCCEED Study. Vaccines, 12(9), 1061. https://doi.org/10.3390/vaccines12091061